Real-world burden of chemotherapy-induced myelosuppression in patients with small cell lung cancer: a retrospective analysis of electronic medical data from community cancer care providers
Author:
Affiliation:
1. Epstein Health, LLC, Woodcliff Lake, NJ, USA
2. Providence Health & Services, Renton, WA, USA
3. Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA
4. G1 Therapeutics, Inc., Research Triangle Park, NC, USA
Funder
G1 Therapeutics, Inc.
Publisher
Informa UK Limited
Subject
Health Policy
Link
https://www.tandfonline.com/doi/pdf/10.1080/13696998.2021.2020570
Reference61 articles.
1. American Society of Clinical Oncology. Lung cancer – small cell: statistics [cited 2021 Jul 1]. Available from: https://www.cancer.net/cancer-types/lung-cancer-small-cell/statistics
2. American Society of Clinical Oncology. Lung cancer – small cell: stages [cited 2021 Jul 1]. Available from: https://www.cancer.net/cancer-types/lung-cancer-small-cell/stages
3. National Comprehensive Cancer Network. Small cell lung cancer (version 3.2021); 2021 [cited 2021 Jul 1]. Available from: https://www.nccn.org/professionals/physician_gls/pdf/sclc.pdf
4. Carboplatin- or Cisplatin-Based Chemotherapy in First-Line Treatment of Small-Cell Lung Cancer: The COCIS Meta-Analysis of Individual Patient Data
5. First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Myeloprotection with trilaciclib in Chinese patients with extensive-stage small cell lung cancer receiving chemotherapy: Results from a randomized, double-blind, placebo-controlled phase III study (TRACES);Lung Cancer;2024-02
2. A Serum-Stable supramolecular drug carrier for chemotherapeutics fabricated by a Peptide-Photosensitizer conjugate;Journal of Colloid and Interface Science;2023-09
3. Real-World Outcomes of Trilaciclib Among Patients with Extensive-Stage Small Cell Lung Cancer Receiving Chemotherapy;Advances in Therapy;2023-07-25
4. Prospective Observational Study on the Risk Factors of Chemotherapy-Induced Myelosuppression and Its Management in a Tertiary Care Hospital;Indian Journal of Medical and Paediatric Oncology;2023-07-05
5. Drivers of Emergency Department Use Among Oncology Patients in the Era of Novel Cancer Therapeutics: A Systematic Review;The Oncologist;2023-06-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3